R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Solving for industry-wide clinical trial development challen...

PurpleLab Managed Services empower clinical development teams to reduce risks and optimise trial execution.

R&D

Company Profile: Recursion

TechBio Recursion is continuously moving toward increased AI, automation, and machine learning modelling.

R&D

Changing Faces – Pharma and Biotech Hires for July 2025

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.

R&D

How synthetic data is overcoming privacy challenges in healt...

The healthcare industry is saturated in data, but accessing the right data, at the right time, remains a persistent challenge.

R&D

Perspectives in viral clearance

Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.

R&D

Xenotransplantation at the brink of breakthrough: A new era ...

In a landmark procedure performed at Massachusetts General Hospital (MGH) on 25th January 2025, a 66-year-old man with end-stage renal disease (ESRD) received a genetically modif